Avelos Therapeutics
About Avelos Therapeutics
The startup develops biomarker-driven targeted therapies that focus on cell cycle regulation, DNA damage response, and previously undruggable cancer targets. This approach enables oncologists to provide more effective treatment options tailored to the specific genetic profiles of tumors, improving patient outcomes in cancer care.
What does Avelos Therapeutics do?
The startup develops biomarker-driven targeted therapies that focus on cell cycle regulation, DNA damage response, and previously undruggable cancer targets. This approach enables oncologists to provide more effective treatment options tailored to the specific genetic profiles of tumors, improving patient outcomes in cancer care.
Where is Avelos Therapeutics located?
Avelos Therapeutics is based in Seoul, South Korea.
When was Avelos Therapeutics founded?
Avelos Therapeutics was founded in 2021.
How much funding has Avelos Therapeutics raised?
Avelos Therapeutics has raised 12400000.
- Location
- Seoul, South Korea
- Founded
- 2021
- Funding
- 12400000
- Employees
- 9 employees
- Major Investors
- Stassets Investment